TickerFacts.

Company research / VTRS

Viatris Inc (VTRS)

Build a valuation ↗↓ Download CSV

CIK 0001792044 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Viatris Inc reported revenue of $14.30B. Revenue fell 3.0% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $14.74B.

Key ratios (year ended 2025-12-31)

35.1%
Gross margin
-18.6%
Operating margin
-24.6%
Net margin
-23.9%
Return on year-end equity
-3.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-08

Headquarters locality: Pittsburgh · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue$14.74B$14.30B$14.74B$15.43B$16.26B$17.89B$11.95B$11.50B$11.43B
Cost of Revenue$9.60B$9.29B$9.12B$8.99B$9.77B$12.31B$8.15B$7.60B$7.43B
Gross Profit$5.13B$5.01B$5.62B$6.44B$6.50B$5.58B$3.80B$3.90B$4.00B
R&D Expensen/a$965.90M$808.70M$805.20M$662.20M$681.00M$512.60Mn/an/a
Operating Income-$87.30M-$2.66B$10.10M$766.20M$1.61B-$34.00M-$210.80M$715.50M$905.60M
Depreciation & Amortization$2.80B$2.80B$2.89B$2.74B$3.03B$4.51B$2.22B$2.02B$2.11B
EBITDA$2.72B$135.20M$2.90B$3.51B$4.64B$4.47B$2.01B$2.73B$3.02B
Net Incomen/a-$3.51B-$634.20M$54.70M$2.08B-$1.27B-$669.90M$16.80M$352.50M
EPS (Diluted)n/a-$3.00-$0.53$0.05$1.71-$1.05-$1.11$0.03$0.68
Total Assets$35.04B$37.19B$41.50B$47.69B$50.02B$54.84B$61.55B$31.26Bn/a
Total Liabilities$20.78B$22.48B$22.87B$27.22B$28.95B$34.35B$38.60B$19.37Bn/a
Shareholders' Equity$14.26B$14.71B$18.64B$20.47B$21.07B$20.49B$22.95B$11.88B$12.17B
Cash & Equivalents$886.50M$1.32B$734.80M$991.90M$1.26B$701.20M$844.40M$475.60M$388.10M
Operating Cash Flow$2.33B$2.32B$2.30B$2.90B$3.00B$3.02B$1.23B$1.80B$2.34B
Capital Expenditures$376.00M$378.80M$326.00M$377.00M$406.00M$457.20M$243.00M$213.20M$252.10M
Free Cash Flow$1.95B$1.94B$1.98B$2.52B$2.59B$2.56B$988.80M$1.59B$2.09B
Share Repurchases$300.10M$500.50M$250.00M$250.00M$0$0$0$0$432.00M
Dividends Per Sharen/a$0.48$0.48$0.48$0.48$0.33n/an/an/a
Weighted Average Diluted Sharesn/an/an/a1.21B1.22B1.21B601.20M516.50M516.50M
EPS (Basic)n/a-$3.00-$0.53$0.05$1.71-$1.05-$1.11$0.03$0.69

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView